Tirzepatide Tablets

25 Tablets

$132.99

Dual GIP/GLP-1 Modulator • Appetite Signaling • Metabolic Research

Tirzepatide is an advanced dual agonist peptide designed to activate both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. This dual-pathway mechanism makes it one of the most powerful and innovative peptides in metabolic, appetite, and endocrine research.

This capsule format delivers 500 mcg (0.5 mg) of Tirzepatide per tablets, ideal for micro-dosing studies, dose-response models, metabolic tracking, and GLP-1/GIP pathway exploration.


KEY RESEARCH HIGHLIGHTS

1. Dual GIP + GLP-1 Receptor Activation

Tirzepatide is unique for its ability to activate two incretin receptors simultaneously, offering:

  • enhanced appetite regulation

  • improved metabolic pathway signaling

  • stronger hormonal feedback loops

This dual action is stronger than GLP-1 alone.


2. Appetite Control & Satiety Response

Research has shown Tirzepatide may influence:

  • hunger signaling in the hypothalamus

  • heightened satiety response

  • slowed gastric emptying

  • reduced caloric intake in metabolic models

This makes it a leading candidate for studies involving energy balance and intake behavior.


3. Glucose & Insulin Modulation

Tirzepatide is widely studied for:

  • improved insulin sensitivity

  • increased β-cell pathway activation

  • glucose stability under metabolic stress

  • improved nutrient processing

Its unique dual-agonist structure allows deeper metabolic insight.


4. Enhanced Metabolic Efficiency

Studies suggest it may support:

  • improved lipid oxidation

  • reduced adipose (fat) accumulation

  • enhanced mitochondrial function

  • optimized metabolic rate

A strong feature for metabolic, endocrine, and longevity research.


5. Novel Incretin Biology Applications

Its hybrid incretin activity allows research into:

  • multi-hormonal signaling

  • advanced metabolic regulation

  • digestive and absorption pathway modulation


CAPSULE FORMAT DETAILS

Strength Per Capsule:

  • 500 mcg (0.5 mg) Tirzepatide

Quantity:

  • 25 capsules per bottle
    (Parfait pour des kits d’essai, micro-dosing, ou starter packs.)

Format:

  • Oral research capsules

  • Laboratory-grade excipients for stability and consistency


Form & Stability

All Peptide Labs research capsules are produced with 99%+ purity for reliability and reproducibility.

Purity:

  • 99%+ (HPLC-tested)

Storage:

  • Store in a cool, dry environment

  • Keep away from heat, moisture, and direct light

  • Keep bottle tightly sealed

Shelf Life:

  • Up to 2 years unopened under proper storage conditions


RESEARCH APPLICATIONS OVERVIEW

  • Dual GIP/GLP-1 receptor activation

  • Appetite & hunger pathway analysis

  • Energy balance & satiety research

  • Glucose and insulin modulation

  • Metabolic rate & lipid oxidation studies

  • Endocrine signaling

  • Digestive and nutrient absorption modeling

  • Multi-incretin hormone biology


MOLECULAR INFORMATION

  • CAS: 2023788-19-2

  • Type: Synthetic Dual Agonist Peptide

  • Molecular Weight: 4813.5 g/mol

  • Form: Oral research capsule